Palforzia becomes first peanut allergy drug to get US approval
The approval marks a “defining moment” for the peanut allergy community.
Read More
Tag: peanut
Peanut allergy vaccine shows promise
There are currently no approved immunotherapies for the treatment of peanut allergies.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
